Latest news

Adapted from a paper presented at EphMRA 2026. Patient journey studies are among the most requested pieces of research in pharma, but increasingly, we’ve noticed they seem to be becoming a little generic. The patient journey brief has become a "must-do" tick-box...

(From Left to Right: Tom Denning - Chief Financial Officer, Emily Routh - Research Director, Niall Baker - Director of Client Services, An-hwa Lee - Senior Research Director) We are delighted to introduce a number of new employees to our global team. Tom Denning joins...

There is a lot of excitement, as well as misunderstanding, around synthetic respondents and digital twins. We’d like to explain exactly what these are, why and when you should use them, and when they need to be treated with caution. And with our behavioural science...

Experiencing a disease journey as a caregiver has highlighted the key challenges faced, and the lens we should use to explore how to change behaviour.  This article explores our Insights Director for APAC, Poh-E’s viewpoint based on her experiences. Click here to read...

We’ve seen the rise and fall of many trends in healthcare innovation—but AI in rare disease care could be a turning point. AI has been part of medicine since the 1970s, but only now does it have the power to truly transform care—especially for rare diseases, where...

Today, the use of Artificial Intelligence (AI) has become habitual to almost the entire workforce and population. It has become an incredibly potent asset to the healthcare industry, aiding greater efficacy in data analysis of clinical trials, diagnostic testing and...

THE CHALLENGE Operating in an established, highly competitive space is a challenge for any brand – how do you make your brand stand out and drive the behaviour change you desire? Our client faced this exact challenge with two core customer segments, one of which...

MedTech companies are building better products than ever. The designs are more intuitive. The workflows are better integrated. The features are deeply aligned to what users say they want. And yet – adoption still stalls. Differentiation still blurs. And commercial...

We have all seen the rise and fall of many a trend (and fad) in communications testing in the hunt for the perfect campaign – and witnessed the success and misfire of many of those campaigns. But what lessons have been learned along the way? Comms testing is all about...

This article explores the impact of cultural influences and stigma on healthcare in the Asia-Pacific region. It examines how cultural stigma affects disease management and offers best practices to reduce stigma, promoting a more inclusive and supportive healthcare...